In summary, Farrerol could effectively inhibit Ang II-induced myocardial remodeling and myocardial hypertrophy in mice, indicating that Farrerol may be a candidate drug for the treatment of myocardial remodeling (Figure 7). The gene discussed is AGT; the disease is cardiac hypertrophy.